Xcout IntelSign inSubscribe

Dexcom

DXCMMedical DevicesSan Diego, United States

DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes management; the Dexcom Real-Time API, enabling authorized third-party developers to integrate live CGM data into their digital health applications; the Dexcom ONE, which aims to supersede traditional finger-prick blood glucose testing for treatment decisions; and Dexcom Share, a remote monitoring platform. The company is also developing the Dexcom G7, its next-generation CGM system. Furthermore, DexCom, Inc. has a licensing and collaboration agreement with Verily Life Sciences LLC and Verily Ireland Limited to advance blood-based or interstitial glucose monitoring products. The company directly sells its offerings to specialists such as endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and maintains its headquarters in San Diego, California.

Subscribe to see Dexcom’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

Dexcom at a glance

Dexcom is a medical devices company headquartered in San Diego, United States, founded in 1999. It is publicly listed (DXCM) with a market capitalisation of $31.5B. Xcout tracks 35 named people at Dexcom, including Jacob Steven Leach (President, CEO & Director). Xcout recorded 142 job postings from Dexcom in the last 90 days.

Industry
Medical Devices
Headquarters
San Diego, United States
Market cap
$31.5B
Employees
11,100
Ticker
DXCM
Founded
1999
Job postings recorded (90 days)
142

Dexcom leadership

  • Jacob Steven LeachPresident, CEO & Director
  • Jacob LeachPresident & Chief Executive Officer
  • Jereme SylvainExecutive VP, CFO, COO & Chief Accounting Officer
  • Peter SimpsonExecutive Vice President & Chief Technology Officer
  • Michael BrownExecutive VP, Chief Legal & Compliance Officer
  • Jon ColemanExecutive Vice President & Chief Commercial Officer

29 more named people on record for Dexcom, with roles, board committees and tenure — see the full roster →

Hiring at Dexcom

Xcout recorded 142 job postings from Dexcom in the last 90 days, from a hiring record Xcout has kept since June 2026.

The weekly hiring trend, the roles and locations behind it — see Dexcom's hiring signals →

Dexcom competitors

A few of Dexcom's closest competitors — see the full list of competitors and alternatives →

Tandem Diabetes Care, Inc.TNDM · Medical DevicesSan Diego, United States
73% matchPublicAI 10/100Green 3/100 ▼

Tandem Diabetes Care, Inc., a medical technology firm, specializes in creating, developing, and marketing solutions for individuals globally who manage insulin-dependent diabetes. At the core of its offerings is the t:slim X2 insulin delivery system, an advanced pump platform that integrates the t:slim X2 pump, a disposable 300-unit insulin cartridge, and an infusion set. Tandem further enhances this platform with innovative features like Basal-IQ and Control-IQ technology, as well as G5 Integration capabilities. The company also provides the Tandem Device Updater, enabling users to easily update their pump's software. To facilitate therapy management, Tandem offers t:connect, a web-based application that visually presents diabetes data from the pump, continuous glucose monitoring (CGM) devices, and supported blood glucose meters to patients, their caregivers, and healthcare professionals. Additionally, the Sugarmate mobile application caters specifically to insulin users with diabetes. Tandem has strategic development and commercialization partnerships with leading companies such as Dexcom, Inc. and Abbott Laboratories. Established in 2006 and headquartered in San Diego, California, the company was initially known as Phluid Inc. before rebranding as Tandem Diabetes Care, Inc. in January 2008.

Market cap$1.1B
Employees2,500
C#JavaScriptAWSAzureDocker
Tandem Diabetes Care, Inc. competitors & alternatives →

Get Dexcom's news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

Dexcom — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on Dexcom in Xcout Intel

  • 35 named people with titles, LinkedIn and board committees
  • Weekly hiring history and the mix of roles behind it
  • 2 corporate events with sources — deals, leadership changes, layoffs
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →